« Return to News | Ethics/Regulatory

Regulatory Affairs Society Provides Regulatory Course Content to Chinese University

Tuesday, May 11, 2010 07:11 AM

The Regulatory Affairs Professionals Society (RAPS) signed an agreement with the University of Shanghai for Science and Technology (USST) to develop regulatory-focused educational content for the Chinese university.

Under the terms of the agreement, RAPS will adapt and offer some of its existing online course content to USST students. RAPS will also help the university develop new regulatory courses. The course content will be initially focused on the regulation of medical devices but could expand to cover other medical products in the future. The audience for the courses will include student-level and novice regulatory professionals, scientists and engineers involved in medical technology research and development, and government inspectors.

 “USST is the only school in China offering bachelor’s, master’s and Ph.D. programs in medical devices and is in an important position for educating and training regulatory professionals in China and internationally,” said Dr. Baolin Liu, professor and dean, School of Medical Instrument and Food Engineering, USST, Shanghai. “We had hoped to partner with RAPS, the leading international regulatory professional organization, and look forward to great success.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.